Patent · US Active

Immunogenic composition

US8431136B2 · kind B2 · utility

10Cited by
18References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2006
Grant dateApr 30, 2013
Priority date
Expiry dateAug 2, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An immunogenic composition comprising a Hib saccharide conjugate and at least two further bacterial saccharide conjugates is provided, wherein the Hib conjugate is present in a lower saccharide dose than the mean saccharide dose of all the at least two further bacterial saccharide conjugates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.